Genmab reported 514M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -102.18M 13.03M
AstraZeneca AZN:LN -292000000 1.38B
Bayer BAYN:GR 2.02B 1.49B
Bluebird Bio BLUE:US $ -135.67M 81.29M
Fresenius Medical Care FME:GR € 449M 56M
Genmab GEN:DC 514M 295M
GRIFOLS GRF:SM € 250.6M 37.64M
Hikma Pharmaceutical HIK:LN 255M 88M
Immunogen IMGN:US $ -22.85M 11.7M
Lonza Group LONN:SW 534M 217M
Novartis NOVN:VX 2.56B 671M
William Demant Holding WDH:DC 1.81B 169M